BCM
MORF

Bayesian Capital Management’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bayesian Capital Management’s Portfolio MORF Stock Details MORF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,900
Closed -$257K – 1188
2023
Q4 		$257K Buy
+8,900
New +$212K 0.03% 545
2023
Q2 		– Sell
-5,624
Closed -$212K – 1125
2023
Q1 		$212K Buy
+5,624
New +$207K 0.03% 600

Other funds holding MORF

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Bayesian Capital Management's MORF Position: Q1 2024 in Review

Bayesian Capital Management sold out of Morphic Holding, Inc. Common Stock (MORF) in Q1 2024, closing a stake of 8,900 shares — an estimated $257K sold.

Bayesian Capital Management first reported a position in MORF in Q1 2023 and held it in 2 quarters. The position peaked at $257K in Q4 2023. 137 funds tracked by Wall St. Rank hold MORF as of Q1 2024.

  • Bayesian Capital Management reported no remaining Morphic Holding, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 8,900 Morphic Holding, Inc. Common Stock shares in Q1 2024, an estimated $257K.
  • Bayesian Capital Management first reported a position in Morphic Holding, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Bayesian Capital Management's Morphic Holding, Inc. Common Stock position peaked at $257K in Q4 2023.
  • 137 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q1 2024.

Based on Bayesian Capital Management's 13F filing for Q1 2024, filed 15 May 2024.